Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACE study of transfusion strategies versus epoetin beta for cancer-related anemia
2006-005965-20Phase 3Terminated
- Sponsor
- Roche
- Start
- Dec 2006
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of epoetin beta and iron sucrose in anaemia (3 arms), sponsored by Roche. Primary endpoint: Maintenance of hemoglobin at or above 110 g/L. Started Dec 2006; status: terminated.
02
Drugs
epoetin betairon sucrose
03
Conditions
anaemia
Beyond the preview
Go deeper on 2006-005965-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005965-20.